Skip to main content
2022 Annual Clinical Assembly (ACA) Main banner
Final Program


ACA Program Book
Back
Video

Cardiothoracic Surgery

General Vascular Surgery

Regenerative Medicine Advanced Therapy (RMAT) In Vascular Surgery, With a Compassionate Vision

Saturday, September 17, 2022
10:30 AM – 10:50 AM East Coast USA Time
Location: JW Grand Ballroom 3
CE: .25
Reference 1: Food and Drug Administration (February 2019). "Expedited Programs for Regenerative Medicine Therapies for Serious Conditions: Guidance for Industry". Food and Drug Administration. Retrieved 25 June 2021.

Reference 2: "Regenerative Medicine Advanced Therapy Designation". Food and Drug Administration. Retrieved 25 June 2021.

Reference 3: Vaggelas, Annegret; Seimetz, Diane (2019-05-01). "Expediting Drug Development: FDA's New Regenerative Medicine Advanced Therapy Designation". Therapeutic Innovation & Regulatory Science. 53 (3): 364–373. doi:10.1177/2168479018779373. ISSN 2168-4804. PMID 29895180. S2CID 48355647

    Member Speaker(s)

  • Duangnapa Cuddy, DO, RPVI.

    Vascular and Endovascular Surgeon
    IU Health Hospital, Bloomington IN
    Indiana University School of Medicine

    Disclosure(s): No financial relationships to disclose

    Slides
Disclosure(s):
Duangnapa Cuddy, DO, RPVI.: No financial relationships to disclose

Learning Objectives:

  1. Understanding definition of Regenerative Medicine Advanced Therapy (RMAT) and its related regulations.
  2. Define Concept of Compassionate Medicine and surgery
  3. Ability to identify relationship between innovation from compassion and benefit to humanity as a whole